Impaired Glucose Tolerance (IGT) Unknown Status Phase 2 Trials for Quercetin-3'-O-phosphate (DB12937)
Also known as: IGT - Impaired Glucose Tolerance / Intolerance to glucose / Impaired Glucose Tolerance (Prediabetes) / Glucose tolerance impaired / Impaired Glucose Tolerance / Glucose Intolerance / Decreased carbohydrate and glucose tolerance / Glucose tolerance decreased / Decreased glucose tolerance / Latent diabetes / Abnormal glucose NOS / Chemical diabetes
Indication | Status | Phase |
---|---|---|
DBCOND0042124 (Impaired Glucose Tolerance (IGT)) | Unknown Status | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT01364155 | Safety, Tolerability, PK, and PD of LIM-0705 in Subjects With Impaired Glucose Tolerance or Abnormal HOMA-IR | Treatment |